Gijón, Spain – 17 December 2020 – Gistem Research S.L., a research company dedicated to the discovery and development of new and innovative applications of mesenchymal stem cells, has announced that it has been granted a patent (PCT/2014/053508) for the use of its Uterine Stem Cells in China. This is in addition to patents already granted in Europe, Russia, Japan and Australia, strengthening the company’s global positioning.
Artículos relacionados
Agreement with the Ministry of Health of Tucumán
Grant date:
US Patent
Grant date:
CODES 2024 Awards
Grant date:
Pelayo de Oro
Grant date:
Stem cell-based drugs: a new era in medicine
Grant date:
Adoptive Son of Gijón
Grant date:
Lecture by Dr. Vizoso, Head of the Research Unit of the Jove Hospital Foundation and Director of the FICEMU Scientific Committee.
Grant date:
Uterine stem cells to treat dry eye
Grant date:
Stem cells to combat ocular inflammation
Grant date:
Nine Asturian companies will attend the international BioSpain meeting
Grant date: